Redwood Grove Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Redwood Grove Capital's MRK Position: Q2 2026 in Review
Redwood Grove Capital sold out of Merck (MRK) in Q2 2026, closing a stake of 30,068 shares — an estimated $3.62M sold.
Redwood Grove Capital first reported a position in MRK in Q1 2021 and held it in 21 quarters. The position peaked at $17M in Q3 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Redwood Grove Capital reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Redwood Grove Capital sold 30,068 Merck shares in Q2 2026, an estimated $3.62M.
- Redwood Grove Capital first reported a position in Merck in Q1 2021 and held it in 21 quarters.
- Redwood Grove Capital's Merck position peaked at $17M in Q3 2024.
- 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Redwood Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.